Age-related macular degeneration and Systemic lupus erythematosus

Summary:

Systemic lupus erythematosus is reported only by a few people with Age-related macular degeneration.

The study analyzes which people have Systemic lupus erythematosus with Age-related macular degeneration. It is created by eHealthMe based on 4 people who have Systemic lupus erythematosus and Age-related macular degeneration from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 30, 2022

4 people who have Age-Related Macular Degeneration and Systemic Lupus Erythematosus are studied.


What is Age-related macular degeneration?

Age-related macular degeneration is found to be associated with 489 drugs and 263 conditions by eHealthMe.

What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 2,094 drugs and 1,449 conditions by eHealthMe.

Number of Systemic lupus erythematosus in Age-related macular degeneration reports submitted per year:

Would you have Systemic lupus erythematosus when you have Age-related macular degeneration?

Gender of people who have Age-Related Macular Degeneration and experienced Systemic Lupus Erythematosus *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Age-Related Macular Degeneration and experienced Systemic Lupus Erythematosus *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 0.0 %
  • 60+: 50 %

Common drugs taken by these people *:

  1. Eylea: 3 people, 75.00%
  2. Beovu: 1 person, 25.00%

Common symptoms for these people *:

  1. Vitritis (inflammation of the vitreous humour of the eye): 1 person, 25.00%
  2. Vitreous Floaters (spots before the eyes): 1 person, 25.00%
  3. Visual Acuity Reduced (reduced clearness of vision): 1 person, 25.00%
  4. Vision Blurred: 1 person, 25.00%
  5. Uveitis (inflammation of the uvea): 1 person, 25.00%
  6. Retinal Haemorrhage (bleeding from retina): 1 person, 25.00%
  7. Periphlebitis (inflammation of tissues around a vein): 1 person, 25.00%
  8. Eye Inflammation: 1 person, 25.00%
  9. Eye Haemorrhage (bleeding in the eye): 1 person, 25.00%
  10. Disease Recurrence: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Systemic lupus erythematosus?

Check whether Systemic lupus erythematosus is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Systemic lupus erythematosus:

Common drugs associated with Systemic lupus erythematosus:

All the drugs that are associated with Systemic lupus erythematosus:

Common conditions associated with Systemic lupus erythematosus:

All the conditions that are associated with Systemic lupus erythematosus:

How the study uses the data?

The study is based on Systemic lupus erythematosus and Age-related macular degeneration, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: